Motion Pictures
- 期刊名称Communication Booknotes
- 作者Beaver, Frank; Dart, Peter; Facey, Paul; Lyons, Timothy J.; McLaughlin, Robert G.; Kael, Pauline; Redding, Robert; Gourlay, Logan; Harrington, John; Lewis, Steven; McQuaid, James; Tait, David; Lee, Rohama
- 卷第5卷
- 期第6期
- 印刷ISSN0748-657X
- 文件大小1750.76KB
- 发表时间1974-02
- DOI10.1080/10948007409489343
- 页码10-11
Rosiglitazone: rosy news for a thiazolidinedioneDoggrell, Sheila A · 2007
Recent Papers by IBM AuthorsDoggrell, Sheila A · IBM Journal of Research and Development · 1976
Pharmacotherapy of intermittent claudicationDoggrell, Sheila A · Expert Opinion on Pharmacotherapy · 2001
Triamcinolone: new and old indicationsDoggrell, Sheila A · Expert Opinion on Pharmacotherapy · 2001
Is zoledronic acid an anticancer drug?Doggrell, Sheila A · Expert Opinion on Pharmacotherapy · 2009
The spironolactone renaissanceDoggrell, Sheila A; Brown, Lindsay · Expert Opinion on Investigational Drugs · 2001
Does rosiglitazone increase cardiovascular outcomes?Doggrell, Sheila A · Expert Opinion on Pharmacotherapy · 2007
Intrathecal ziconotide for refractory painDoggrell, Sheila A · Expert Opinion on Investigational Drugs · 2004
Inhibitors of the anaplastic lymphoma kinaseMologni, Luca · Expert Opinion on Investigational Drugs · 2012
Melatonin in cardiovascular diseaseDominguez-Rodriguez, Alberto · Expert Opinion on Investigational Drugs · 2012
Drugs for bone healingBrandi, Maria Luisa · Expert Opinion on Investigational Drugs · 2012
Rheumatoid arthritis: developing pharmacological therapiesMoreland, Larry W; Misischia, Richard J · Expert Opinion on Investigational Drugs · 2002
New and investigational antiepileptic drugsStriano, Pasquale; Striano, Salvatore · Expert Opinion on Investigational Drugs · 2009
Ertapenem: a new carbapenemOdenholt, Inga · Expert Opinion on Investigational Drugs · 2001
Recent developments in carbapenemsNicoletti, Giuseppe; Russo, Giovanni; Bonfiglio, Giovanni · Expert Opinion on Investigational Drugs · 2002
The immunotherapeutic potential of melatoninMaestroni, Georges JM · Expert Opinion on Investigational Drugs · 2001